NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Brightspring Health executive buys $303k in company stock

Published 03/16/2024, 05:40 AM
© Reuters.
BTSG
-

BrightSpring Health Services, Inc. (NYSE:BTSG) has reported a significant purchase of shares by Jon B. Rousseau, the company's Chairman, President, and Chief Executive Officer. According to the latest SEC filing, Rousseau acquired 37,405 shares of common stock at a weighted average price of $8.12, totaling approximately $303,728.

The transaction, which took place on March 14, 2024, was part of a series of purchases at prices ranging from $7.95 to $8.23. The filing indicated that these shares were bought in multiple transactions, and Rousseau has committed to providing detailed information about the number of shares acquired at each price point if requested.

Following this transaction, Rousseau's direct holdings in the company increased to 39,352 shares. Additionally, the filing disclosed that he has an indirect ownership through the Rousseau Family Trust, which holds 351,363 shares of BrightSpring Health's common stock. The executive has stated that the filing should not be construed as an admission of beneficial ownership of the reported securities, except to the extent of his pecuniary interest.

Investors often monitor insider transactions such as these for insights into executive confidence in the company's prospects. BrightSpring Health Services, based in Louisville, Kentucky, specializes in home health care services. The company's stock is publicly traded on the New York Stock Exchange under the ticker symbol BTSG.

InvestingPro Insights

In light of the recent insider stock purchase by BrightSpring Health Services' CEO, Jon B. Rousseau, investors are keen to understand the company's financial health and future prospects. According to InvestingPro data, BrightSpring Health Services has a market capitalization of approximately $1.41 billion, reflecting the value the market currently places on the company. Despite the company's negative P/E ratio of -6.91, which indicates that it has not been profitable over the last twelve months, analysts are optimistic about the company's potential to turn profitable this year.

Furthermore, the company has demonstrated impressive revenue growth, with a 14.32% increase over the last twelve months as of Q4 2023, and an even more substantial quarterly revenue growth of 20.5% in Q1 2023. This growth trajectory suggests that BrightSpring Health Services is expanding its market presence and improving its financial performance. Additionally, the company's stock has recently been trading near its 52-week low, which could indicate a potential buying opportunity for investors, especially considering the CEO's recent stock purchase.

An InvestingPro Tip notes that the stock's Relative Strength Index (RSI) suggests it is in oversold territory, which often attracts investors looking for undervalued stocks that may be due for a rebound. Moreover, the stock has taken a significant hit over the last week, with a price total return of -9.16%, which could be a reaction to broader market trends or company-specific events.

For those interested in further analysis and additional InvestingPro Tips, such as the company's valuation implying a strong free cash flow yield, you can find more at InvestingPro. There are a total of 9 additional tips available to help deepen your understanding of BrightSpring Health Services' investment profile. Remember to use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, enriching your investment research with valuable insights.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.